Rat brain serotonin neurones that express neuronal nitric oxide synthase have increased sensitivity to the substituted amphetamine serotonin toxins 3,4-methylenedioxymethamphetamine and p-chloroamphetamine

Neuroscience

Volumn 134, Issue 4, 2005, Pages 1363-1375

  De Silva, D J ^a,c   French, S J ^a   Cheung, N Y ^a   Swinson, A K ^a   Bendotti, C ^b   Rattray, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c WESTERN EYE HOSPITAL   (United Kingdom)

Author keywords

5,7 DHT; 5 hydroxytryptamine; Ecstasy; Nitric oxide synthase; Serotonin transporter

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; CHLORAMPHETAMINE; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; SEROTONIN DERIVATIVE; SEROTONIN TRANSPORTER; TOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DORSAL RAPHE NUCLEUS; DOWN REGULATION; ENZYME LOCALIZATION; FRONTAL CORTEX; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SEROTONINERGIC NERVE CELL; WESTERN BLOTTING;

3,4-METHYLENEDIOXYAMPHETAMINE; ANIMALS; BLOTTING, WESTERN; BRAIN; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEURONS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; P-CHLOROAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 23944458519     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.05.016     Document Type: Article

References (58)

1. C. Bendotti, S. Baldessari, M. Ehret, G. Tarizzo, R. Samanin Effect of d-fenfluramine and 5,7-dihydroxytryptamine on the levels of tryptophan hydroxylase and its mRNA in rat brain Mol Brain Res 19 1993 257 261
2. R.D. Blakely, H.E. Berson, R.T. Fremeau Jr, M.G. Caron, M.M. Peek, H.K. Prince, C.C. Bradley Cloning and expression of a functional serotonin transporter from rat brain Nature 354 1991 66 70
3. D.S. Bredt, P.M. Hwang, C.E. Glatt, C. Lowenstein, R.R. Reed, S.H. Snyder Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase Nature 351 1991 714 718
4. P. Brown, M.E. Molliver Dual serotonin (5-HT) projections to the nucleus accumbens core and shell relation of the 5-HT transporter to amphetamine-induced neurotoxicity J Neurosci 20 2000 1952 1963
5. J.L. Cadet, B. Ladenheim, H. Hirata, R.B. Rothman, S. Ali, E. Carlson, C. Epstein, T.H. Moran Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA) evidence from using CuZn-superoxide dismutase transgenic mice Synapse 21 1995 169 176
6. J. Camarero, V. Sanchez, E. O'Shea, A.R. Green, M.I. Colado Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ("ecstasy")-induced dopamine release and free radical formation in the mouse striatum J Neurochem 81 2002 961 972
7. M.I. Colado, A.R. Green The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents "ecstasy"-induced neurodegeneration of 5-hydroxytryptamine neurones Eur J Pharmacol 280 1995 343 346
8. M.I. Colado, E. O'Shea, R. Granados, T.K. Murray, A.R. Green In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("ecstasy") and p-chloroamphetamine but not the degeneration following fenfluramine Br J Pharmacol 121 1997 889 900
9. M.I. Colado, E. O'Shea, R. Granados, B. Esteban, A.B. Martin, A.R. Green Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") administration Br J Pharmacol 126 1999 911 924
10. A.S. Darvesh, B.K. Yamamoto, G.A. Gudelsky Evidence for involvement of nitric oxide in 3,4-methyelenedioxymethamphetamine-induced serotonin depletion in the rat brain J Pharmacol Exp Ther 312 2005 694 701
11. T.M. Dawson, J. Zhang, V.L. Dawson, S.H. Snyder Nitric oxide cellular regulation and neuronal injury Prog Brain Res 103 1994 365 369
12. V.L. Dawson, T.M. Dawson Nitric oxide in neurodegeneration Prog Brain Res 118 1998 215 229
13. F. Fernandez, S. Aguerre, P. Mormede, F. Chaouloff Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats Eur J Neurosci 16 2002 607 618
14. R.W. Fuller Effects of p-chloroamphetamine on brain serotonin neurons Neurochem Res 17 1992 449 456
15. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol Rev 55 2003 463 508
16. S.Z. Imam, G.D. Newport, Y. Itzhak, J.L. Cadet, F. Islam, W. Slikker Jr, S.F. Ali Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase J Neurochem 76 2001 745 749
17. K. Iwase, K. Iyama, K. Akagi, S. Yano, K. Fukunaga, E. Miyamoto, M. Mori, M. Takiguchi Precise distribution of neuronal nitric oxide synthase mRNA in the rat brain revealed by non-radioisotopic in situ hybridization Mol Brain Res 53 1998 1 12
18. M.D. Johnson, P.M. Ma Localization of NADPH diaphorase activity in monoaminergic neurons of the rat brain J Comp Neurol 332 1993 391 406
19. A. Kanthasamy, J.E. Sprague, J.R. Shotwell, D.E. Nichols Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum Neuroscience 114 2002 917 924
20. S.A. Lipton, Y.B. Choi, Z.H. Pan, S.Z. Lei, H.S. Chen, N.J. Sucher, J. Loscalzo, D.J. Singel, J.S. Stamler A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds Nature 364 1993 626 632
21. G.M. MacKenzie, S. Rose, P.A. Bland-Ward, P.K. Moore, P. Jenner, C.D. Marsden Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole Neuroreport 5 1994 1993 1996
22. J.E. Malberg, L.S. Seiden Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat J Neurosci 18 1998 5086 5094
23. L.A. Mamounas, M.E. Molliver Evidence for dual serotonergic projections to neocortex axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA) Exp Neurol 102 1988 23 36
24. L.A. Mamounas, C.A. Mullen, E. O'Hearn, M.E. Molliver Dual serotoninergic projections to forebrain in the rat morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives J Comp Neurol 314 1991 558 586
25. U.D. McCann, A. Ridenour, Y. Shaham, G.A. Ricaurte Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") a controlled study in humans Neuropsychopharmacology 10 1994 129 138
26. U.D. McCann, Z. Szabo, U. Scheffel, R.F. Dannals, G.A. Ricaurte Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings Lancet 352 1998 1433 1437
27. T.K. Murray, J.L. Williams, A. Misra, M.I. Colado, A.R. Green The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine Neuropharmacology 35 1996 1615 1620
28. J.F. Nash, H.Y. Meltzer, G.A. Gudelsky Effect of 3,4- methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens J Neurochem 54 1990 1062 1067
29. D.E. Nichols, J.F. Nash Microdialysis studies on 3,4- methylenedioxyamphetamine and structurally related analogues Eur J Pharmacol 200 1991 53 58
30. E. O'Hearn, G. Battaglia, E.B. De Souza, M.J. Kuhar, M.E. Molliver Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain immunocytochemical evidence for neurotoxicity J Neurosci 8 1988 2788 2803
31. G. Paxinos, C. Watson The rat brain in stereotaxic coordinates 3rd ed 1997 Academic Press San Diego
32. A.J. Ramos, P. Tagliaferro, J.J. Lopez-Costa, E.M. Lopez, S.J. Pecci, A. Brusco Neuronal and inducible nitric oxide synthase immunoreactivity following serotonin depletion Brain Res 958 2002 112 121
33. M. Rattray, S. Baldessari, M. Gobbi, T. Mennini, R. Samanin, C. Bendotti p-Chlorophenylalanine changes serotonin transporter mRNA levels and expression of the gene product J Neurochem 67 1996 463 472
34. M. Rattray, G.J. Michael, J. Lee, G. Wotherspoon, C. Bendotti, J.V. Priestley Intraregional variation in expression of serotonin transporter messenger RNA by 5-hydroxytryptamine neurons Neuroscience 88 1999 169 183
35. M. Rattray, G. Wotherspoon, D. Savery, S. Baldessari, C. Marden, J.V. Priestley, C. Bendotti Chronic D-fenfluramine decreases serotonin transporter messenger RNA expression in dorsal raphe nucleus Eur J Pharmacol 268 1994 439 442
36. R.B. Rothman, S. Jayanthi, X. Wang, C.M. Dersch, J.L. Cadet, T. Prisinzano, K.C. Rice, M.H. Baumann High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain Synapse 50 2003 233 239
37. G. Rudnick, S.C. Wall p-Chloroamphetamine induces serotonin release through serotonin transporters Biochemistry 31 1992 6710 6718
38. G. Rudnick, S.C. Wall The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)] serotonin transporters are targets for MDMA-induced serotonin release Proc Natl Acad Sci U S A 89 1992 1817 1821
39. V. Sanchez, M. Zeini, J. Camarero, E. O'Shea, L. Bosca, A.R. Green, M.I. Colado The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum J Neurochem 85 2003 515 524
40. U. Scheffel, G.A. Ricaurte Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity a presynaptic serotonergic positron emission tomography ligand? Brain Res 527 1990 89 95
41. C.J. Schmidt, C.K. Black, G.M. Abbate, V.L. Taylor Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors Brain Res 529 1990 85 90
42. C.J. Schmidt, C.K. Black, V.L. Taylor Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine Eur J Pharmacol 181 1990 59 70
43. C.J. Schmidt, L. Wu, W. Lovenberg Methylenedioxymethamphetamine a potentially neurotoxic amphetamine analogue Eur J Pharmacol 124 1986 175 178
44. J.B. Schulz, R.T. Matthews, M.M. Muqit, S.E. Browne, M.F. Beal Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice J Neurochem 64 1995 936 939
45. M. Shankaran, B.K. Yamamoto, G.A. Gudelsky Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT Synapse 40 2001 55 64
46. R. Simantov, M. Tauber The abused drug MDMA (ecstasy) induces programmed death of human serotonergic cells FASEB J 11 1997 141 146
47. K.L. Simpson, B.D. Waterhouse, R.C. Lin Differential expression of nitric oxide in serotonergic projection neurons neurochemical identification of dorsal raphe inputs to rodent trigeminal somatosensory targets J Comp Neurol 466 2003 495 512
48. P. Tagliaferro, A.J. Ramos, J.J. Lopez-Costa, E.M. Lopez, J.P. Saavedra, A. Brusco Increased nitric oxide synthase activity in a model of serotonin depletion Brain Res Bull 54 2001 199 205
49. T. Taraska, K.T. Finnegan Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine J Pharmacol Exp Ther 280 1997 941 947
50. Q.P. Wang, J.L. Guan, Y. Nakai Distribution and synaptic relations of NOS neurons in the dorsal raphe nucleus a comparison to 5-HT neurons Brain Res Bull 37 1995 177 187
51. X. Wang, M.H. Bauman, H. Xu, R.B. Rothman 3,4- Methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein Synapse 53 2004 240 248
52. M.A. Wilson, G.A. Ricaurte, M.E. Molliver Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine Neuroscience 28 1989 121 137
53. G. Wotherspoon, M. Albert, M. Rattray, J.V. Priestley Serotonin and NADPH-diaphorase in the dorsal raphe nucleus of the adult rat Neurosci Lett 173 1994 31 36
54. Z.Q. Xu, T. Hokfelt Expression of galanin and nitric oxide synthase in subpopulations of serotonin neurons of the rat dorsal raphe nucleus J Chem Neuroanat 13 1997 169 187
55. S.Y. Yeh Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats Pharmacol Biochem Behav 58 1997 701 708
56. P.K. Yip, B.S. Meldrum, M. Rattray Elevated levels of group-III metabotropic glutamate receptors in the inferior colliculus of genetically epilepsy-prone rats following intracollicular administration of l-serine-O-phosphate J Neurochem 78 2001 13 23
57. F. Zhang, J.G. White, C. Iadecola Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia evidence that nitric oxide is beneficial in the early stages of cerebral ischemia J Cereb Blood Flow Metab 14 1994 217 226
58. Y. Zheng, R. Laverty Role of brain nitric oxide in (+/-)3,4- methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats Brain Res 795 1998 257 263